Purpose/Objective: The aim of this study is to assess accuracy and efficiency of a novel approach to mitigate and track target motion during hypo-fractionated prostate cancer treatment. Materials and Methods: In our institution, most patients with low and intermediate risk prostate cancer are treated with 5 times 9 Gy to the PTV, which consists of the CTV + 2mm. Patients anatomy reproducibility is improved by virtue of a rectal balloon with a personalized volume of air (median 150cc). Three beacon transponders are placed intraurethrally by means of a Foley catheter to identify anatomy and allow intra-fractional tracking with the Calypso system (Varian). Before beam delivery, CBCTs are acquired and the 6DoF couch is moved to closely match the reference treatment position. Thus, the Calypso system is reset to zero, and the treatment is started with tracking in place. Whenever motion beyond 2mm is detected for at least 5 seconds, treatment will be interrupted. We used raw Calypso data instead of the zero-corrected data for motion analysis. First, raw Calypso readings were offset corrected by subtraction of the mean reading during reference CBCT acquisition, using linac log files for CBCT timings. Couch shifts between reference CBCT and treatment were corrected using table positions from ARIA. We then determined per fraction the mean corrected Calypso position (m f ) and the standard deviation (sd f ) during beam delivery. This yielded means (m p =<m f >) and SD (sd p =SD(m f )) per patient. Finally, the overall mean (μ=<m p >), the systematic (Σ=SD(m p )), and the inter-(σ inter =<sd p >) and intra-fraction (σ intra =<sd f >) random uncertainties were used to characterize the accuracy of our approach. Overall treatment duration, #CBCTs, and beam delivery times are established using the ARIA database.
Results
The table summarizes treatment times and motion results. We analysed 291 fractions from our first 63 five-fraction treatments. On average, 2.5 CBCTs were acquired prior to and 1 after start of beam delivery. Total treatment time lasted on average 20 minutes, of which 15 minutes preparation time and 5 minutes beam delivery time. With growing experience, treatment has become faster (from 24 to 18 min). In total 20 treatment interruptions (7%) were needed. Regarding motion analysis, for 169 fractions of 43 patients all required data were available. Sub-millimetre accuracy was observed in all directions resulting in margins (for the beacon motions only) < 2mm. Nevertheless, the accuracy and the treatment duration can be further improved. For instance, Calypso should always be reset to zero during and not after acquisition of the reference CBCT to avoid e.g. false-negatives due to the gradual beacon motions. Conclusions: Our novel approach for prostate positioning keeps the average target motions within 2mm. Further finetuning of the procedure should make the intra-fraction motions truly negligible.
